TBX3
Basic information
Region (hg38): 12:114670255-114684175
Previous symbols: [ "UMS" ]
Links
Phenotypes
GenCC
Source:
- ulnar-mammary syndrome (Definitive), mode of inheritance: AD
- heart conduction disease (Limited), mode of inheritance: AD
- ulnar-mammary syndrome (Strong), mode of inheritance: AD
- ulnar-mammary syndrome (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ulnar-Mammary syndrome | AD | Cardiovascular | Cardiac anomalies, including arrhythmias, have been reported, and surveillance may allow early detection and management | Cardiovascular; Dental; Endocrine; Genitourinary; Musculoskeletal; Renal | 9207801; 12116211; 12668170; 19938096; 21199695; 28145909 |
ClinVar
This is a list of variants' phenotypes submitted to
- Ulnar-mammary syndrome (7 variants)
- TBX3-related disorder (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TBX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 108 | 10 | 122 | |||
missense | 162 | 177 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 11 | |||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 4 | 8 | |||
non coding | 46 | 32 | 36 | 114 | ||
Total | 8 | 11 | 221 | 149 | 48 |
Variants in TBX3
This is a list of pathogenic ClinVar variants found in the TBX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-114670285-A-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670301-GA-G | Ulnar-mammary syndrome | Uncertain significance (Jun 14, 2016) | ||
12-114670331-T-C | Ulnar-mammary syndrome | Benign (Jan 29, 2024) | ||
12-114670459-C-G | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670464-G-A | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670501-C-T | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114670529-A-G | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114670556-T-C | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114670577-G-C | Ulnar-mammary syndrome | Benign (Jan 12, 2018) | ||
12-114670617-A-G | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114670654-C-T | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670660-C-T | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670755-TAAC-T | Ulnar-mammary syndrome | Likely benign (Jun 14, 2016) | ||
12-114670767-T-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114670951-T-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114671046-T-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114671094-C-T | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114671102-T-C | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114671126-G-C | Ulnar-mammary syndrome | Uncertain significance (Jan 12, 2018) | ||
12-114671270-G-C | Ulnar-mammary syndrome | Benign (Jan 13, 2018) | ||
12-114671312-C-T | Ulnar-mammary syndrome | Uncertain significance (Jan 12, 2018) | ||
12-114671339-T-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114671370-A-C | Ulnar-mammary syndrome | Uncertain significance (Jan 13, 2018) | ||
12-114671418-C-G | Ulnar-mammary syndrome | Benign (Jan 12, 2018) | ||
12-114671434-A-G | Ulnar-mammary syndrome | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TBX3 | protein_coding | protein_coding | ENST00000257566 | 8 | 13911 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.989 | 0.0109 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.73 | 343 | 446 | 0.769 | 0.0000256 | 4767 |
Missense in Polyphen | 95 | 168.68 | 0.56321 | 1900 | ||
Synonymous | -0.858 | 216 | 201 | 1.08 | 0.0000134 | 1520 |
Loss of Function | 4.00 | 2 | 22.4 | 0.0892 | 0.00000109 | 268 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000380 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor involved in developmental processes. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence. {ECO:0000269|PubMed:10468588, ECO:0000269|PubMed:22002537}.;
- Pathway
- Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Mesodermal Commitment Pathway;Preimplantation Embryo
(Consensus)
Recessive Scores
- pRec
- 0.191
Intolerance Scores
- loftool
- 0.00413
- rvis_EVS
- -0.73
- rvis_percentile_EVS
- 14.08
Haploinsufficiency Scores
- pHI
- 0.932
- hipred
- Y
- hipred_score
- 0.809
- ghis
- 0.653
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.975
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tbx3
- Phenotype
- skeleton phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype;
Zebrafish Information Network
- Gene name
- tbx3a
- Affected structure
- fin bud
- Phenotype tag
- abnormal
- Phenotype quality
- aplastic
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;skeletal system development;blood vessel development;in utero embryonic development;heart looping;outflow tract morphogenesis;atrioventricular bundle cell differentiation;regulation of transcription by RNA polymerase II;cell aging;positive regulation of cell population proliferation;anterior/posterior axis specification, embryo;animal organ morphogenesis;specification of animal organ position;stem cell population maintenance;limbic system development;male genitalia development;female genitalia development;negative regulation of epithelial cell differentiation;mammary gland development;luteinizing hormone secretion;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;forelimb morphogenesis;embryonic digit morphogenesis;negative regulation of apoptotic process;negative regulation of myoblast differentiation;positive regulation of cell cycle;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;follicle-stimulating hormone secretion;mesoderm morphogenesis;roof of mouth development;ventricular septum morphogenesis;branching involved in mammary gland duct morphogenesis;mammary placode formation;cardiac muscle cell fate commitment;sinoatrial node cell development;cellular senescence;positive regulation of stem cell proliferation
- Cellular component
- nucleus
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;RNA polymerase II activating transcription factor binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding